POLYGON Therapeutics
PrivateLast Round
Seed
Nov 8, 2024
Total Funding Raised
$8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
POLYGON Therapeutics operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in November 2024.
POLYGON Therapeutics is a drug discovery company that provides a therapeutic development program to improve cardiovascular disease care and mitigate the damage inflicted on the heart.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
POLYGON Therapeutics Comparables
Compare POLYGON Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bitterroot Bio | 81% | |
| Beijing Sungen Biomedical Technology Co., Ltd. | 78% | |
| Cartio Therapeutics | 76% |
For institutional investors. Book with your work email.
POLYGON Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 8, 2024 | ||||
| Grant | Apr 18, 2023 | ||||
| Pre Seed | Sep 8, 2022 | ||||
| Grant | Jul 7, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
POLYGON Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agoranov | Pre Seed |
| Région Île-de-France | Grant |
| Audacia | Seed |
| Inserm Transfert | Pre Seed |
| EIT Health | Seed |
| Sorbonne Venture | Seed |
| Bpifrance | Grant, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 363% MoM.
- Jan 1, 2026
Monthly visitors increased 42% MoM.
For institutional investors. Book with your work email.
POLYGON Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about POLYGON Therapeutics's valuation, stock price, and market status.
Is POLYGON Therapeutics a public or private company?
POLYGON Therapeutics is a private company.
What is the current stock price of POLYGON Therapeutics?
POLYGON Therapeutics is a private company, so its shares have no public market price. Caplight tracks POLYGON Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is POLYGON Therapeutics worth (valuation)?
Valuation information for POLYGON Therapeutics is not publicly available.
Can I buy POLYGON Therapeutics stock?
POLYGON Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was POLYGON Therapeutics's last funding round?
POLYGON Therapeutics's most recent funding round was Seed on November 8, 2024.
Who are the main investors in POLYGON Therapeutics?
Key investors in POLYGON Therapeutics include Sorbonne Venture.
Will POLYGON Therapeutics IPO soon?
No public IPO plans have been announced for POLYGON Therapeutics.
How can I track POLYGON Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in POLYGON Therapeutics's shares on secondary markets.